2,3-dihydro-1,2-diphenyl-substituted 4H-pyridinone derivatives as new anti flaviviridae inhibitors

Chemical Biology and Drug Design

Volumn 77, Issue 6, 2011, Pages 441-449

  Peduto, Antonella ^a   Massa, Antonio ^a   Di Mola, Antonia ^a   de Caprariis, Paolo ^a   La Colla, Paolo ^b   Loddo, Roberta ^b   Altamura, Sergio ^c   Maga, Giovanni ^d   Filosa, Rosanna ^a  

^a UNIVERSITY OF SALERNO   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c IRBM   (Italy)

^d CNR   (Italy)

Author keywords

2,3 dihydro 1,2 diphenyl substituted 4H pyridinone; Flavivirus

Indexed keywords

2 (4 CHLOROPHENYL) 4 ETHOXY 1,2,3,4 TETRAHYDRO 3,5 DIMETHYL 1 (4 NITROPHENYL)PYRIDINE; 2,3 DIHYDRO 3,5 DIMETHYL 1 (4 NITROPHENYL) 2 (4 TRIFLUOROMETHYLPHENYL)PYRIDIN 4(1H) ONE; AURINTRICARBOXYLIC ACID; PYRIDONE DERIVATIVE; RNA DIRECTED RNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; DRUG CYTOTOXICITY; DRUG SYNTHESIS; FLAVIVIRIDAE INFECTION; FLAVIVIRUS; HEPATITIS C VIRUS; NONHUMAN; PESTIVIRUS; PRIORITY JOURNAL;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; FLAVIVIRIDAE; FLAVIVIRIDAE INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; PYRIDONES; STRUCTURE-ACTIVITY RELATIONSHIP;

ACIS; BOVINAE; FLAVIVIRIDAE; FLAVIVIRUS; HEPATITIS C VIRUS; YELLOW FEVER VIRUS;

EID: 79955964401     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2011.01102.x     Document Type: Article

References (27)

1. Neukam K., Macías J., Mira J.A., Pineda J.A. (2009) A review of current anti-HCV treatment regimens and possible future strategies. Expert Opin Pharmacother;10:417-433.
2. Tan S.L., Shi Y., Sonenberg N. (2002) Hepatitis C therapeutics: current status and emerging strategies. Nat Rev Drug Discov;1:867-881.
3. Lidenbach B.D., Rice C.M. (2001) Flaviviridae: the viruses and their replication. In: Fields B.N., Knipe D.M., Howley P.M., Griffin D.E., editors. Fields' Virology. Philadelphia, PA, USA: Lippincott Williams & Wilkins; p. 991-1042.
4. Carman S., Van Dreumel T., Ridpath J., Hazlett M., Alves D., Dubovi E., Tremblay R., Bolin S., Godkin A., Anderson N. (1998) Severe acute bovine viral diarrhea in Ontario, 1993-1995. J Vet Diagn Invest;10:27-35.
5. Deregt D., Loewen K.G. (1995) Bovine viral diarrhea virus: biotypes and disease. Can Vet J;36:371-378.
6. Pellerin C., van den Hurk J., Lecomte J., Tussen P. (1994) Identification of a new group of bovine viral diarrhea virus strains associated with severe outbreaks and high mortalities. Virology;203:260-268.
7. Buckwold V.E., Beer B.E., Donis R.O. (2003) Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents. Antiviral Res;60:1-15.
8. O'Boyle D.R., Nower P.T., Lemm J.A., Valera L., Sun J.H., Rigat K., Colonno R., Gao M. (2005) Development of a cell-based high-throughput specificity screen using a hepatitis C virus-bovine viral diarrhea virus dual replicon assay. Antimicrob Agents Chemother;49:1346-1353.
9. Bartenschlager R., Lohmann V. (2001) Novel cell culture systems for the hepatitis C virus. Antiviral Res;52:1-17.
10. Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R., McKeating J.A., Rice C.M. (2005) Complete replication of hepatitis C virus in cell culture. Science;309:623-626.
11. Michielsen P.P., Francque S.M., Van Dongen J.L. (2005) Viral hepatitis and hepatocellular carcinoma. World J Surg Oncol;3:27.
12. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H.G., Mizokami M., Bartenschlager R., Liang T.J. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med;11:791-796.
13. Bartenschlager R. (2002) Innovation: hepatit C virus replicons: potential role for drug development. Nat Rev Drug Discov;1:911-916.
14. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D.R., Wieland S.F., Uprichard S.L., Wakita T., Chisari F.V. (2005) Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA;26:9294-9299.
15. Pawlotsky J.M., Chevaliez S., McHutchison J.G. (2007) The hepatitis C virus life cycle as a target for new antiviral therapies. Gastroenterology;132:1979-1998.
16. Hoofnagle J.H., Seef L.B. (2007) Peginterferon and ribavirin for chronic hepatitis C. N Engl J Med;355:2444-2451.
17. Pauwels R., Balzarini J., Baba M., Snoeck R., Schols D., Herdewijn P., Desmyster J., De Clerq E. (1988) Rapid and automated tetrazolium-based colorimetric assay for the detection of Anti-HIV compounds. J Virol Methods;20:309-321.
18. Lohmann V., Korner F., Koch J., Henan U., Theilmann L., Bartenschlager R. (1999) Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science;285:110-113.
19. Chen Y., Bopda-Waffo A., Basu A., Krishnan R., Silberstein E., Taylor D.R., Talele T.T., Arora P., Kaushik-Basu N. (2009) Characterization of aurintricarboxylic acid as a potent hepatitis C virus replicase inhibitor. Antivir Chem Chemother;20:19-36.
20. Massa A., De Sio V., Villano R., Acocella M.R., Palombi L., Sellitto G., Peduto A., Filosa R., De Caprariis P., Scettri A. (2009) A new approach to Di- and tetrasubstituted 2, 3-dihydropyridin-4(1H)- ones through Aza-Diels-Alder reaction promoted by silicon tetrachloride. Synthesis;4:643-649.
21. Etayo P., Badorrey R., Díaz-de-Villegas M.D., Gálvez J.A. (2008) Stereoselective synthesis of chiral 2, 3-disubstituted-2, 3-dihydro-4(1H)-pyridones. Eur J Org Chem;35:6008-6014.
22. Kozikowski A.P., Park P. (1990) Synthesis of streptazolin: use of the aza-Ferrier reaction in conjunction with the INOC process to deliver a unique but sensitive natural product. J Org Chem;55:4668-4682.
23. Beherens S.E., Tomei L., De Frencesco R. (1996) Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. EMBO J;15:12-22.
24. Frick D.N. (2004) The hepatitis C virus replicase: insights into RNA-dependent RNA replication and prospects for rational drug design. Curr Org chem;3:223-241.
25. Wu J.Z., Hong Z. (2003) Targeting NS5B RNA-dependent RNA polymerase for anti-HCV chemotherapy. Curr Drug Targets Infect Disord;3:207-219.
26. Hagedorn C.H., Van Beers E.H., De Staercke C. (2000) Hepatitis C virus RNA-dependent RNA polymerase (NS5B polymerase). Curr Top Microbiol Immunol;242:225-260.
27. Watkins W.J., Ray A.S., Chong L.S. (2010) HCV NS5B polymerase inhibitors. Curr Opin Drug Discov Devel;13:441-465.